Novel Benzothiazole-Based Ureas as 17β-HSD10 Inhibitors, A Potential Alzheimer's Disease Treatment Article

Aitken, Laura, Benek, Ondrej, McKelvie, Brogan E et al. (2019). Novel Benzothiazole-Based Ureas as 17β-HSD10 Inhibitors, A Potential Alzheimer's Disease Treatment . Molecules, 24(15), 10.3390/molecules24152757

Open Access International Collaboration

cited authors

  • Aitken, Laura; Benek, Ondrej; McKelvie, Brogan E; Hughes, Rebecca E; Hroch, Lukas; Schmidt, Monika; Major, Louise L; Vinklarova, Lucie; Kuca, Kamil; Smith, Terry K; Musilek, Kamil; Gunn-Moore, Frank J

sustainable development goals

authors

publication date

  • August 1, 2019

published in

keywords

  • 17 beta-hydroxysteroid dehydrogenase type 10 (17 beta-HSD10)
  • A-BETA
  • ABAD/17-BETA-HSD10
  • AMYLOID-BETA-PEPTIDE
  • ANALOGS
  • Alzheimer's disease (AD)
  • BINDING
  • Biochemistry & Molecular Biology
  • Chemistry
  • Chemistry, Multidisciplinary
  • DESIGN
  • Life Sciences & Biomedicine
  • Physical Sciences
  • Science & Technology
  • amyloid binding alcohol dehydrogenase (ABAD)
  • amyloid-beta peptide (A beta)
  • benzothiazole
  • mitochondria

Digital Object Identifier (DOI)

volume

  • 24

issue

  • 15